Company Overview: PolyNovo Limited is a medical device company. The Company designs, develops and manufactures solutions for standalone and combination devices using its NovoSorb biodegradable polymer technology. The Company focuses on medical devices that are used in the treatment of burns, surgical wounds and negative pressure wound therapy (NPWT). It is involved in the development of NovoPore for use as a dressing in NPWT that involves a wound-contacting foam dressing, a sealing membrane, a suction pump, and a drainage tube from the dressing to a canister, and Biodegradable Temporising Matrix (BTM), a wound dressing focused on treatment of full-thickness wounds and burns where the dermal structure has been lost to trauma, or damaged requiring surgical removal, and requires a split-thickness skin graft for final closure. In addition, the Company is engaged in the development of breast sling prototypes for non-clinical and clinical trials, as well as new products for hernia and breast reconstructions.
© Data powered by Morningstar, Inc. 2023. All rights reserved.
Neither Morningstar, its affiliates, nor the content providers guarantee the
market indices, commodities and regulatory news headlines, and other data or
content contained herein to be accurate, complete, or timely, and nor shall
they have any liability for its use or distribution. The data contained
herein: (1) is proprietary to Morningstar and/or its affiliates
(collectively, “Morningstar”) and/or their content providers; (2) may not be
copied or distributed; and (3) is not warranted to be accurate, complete, or
timely. Our publications, ratings and products should be viewed as an
additional investment resource, and not as your sole source of information.
Past performance does not necessarily indicate a financial product’s future
performance. To obtain advice tailored to your financial situation, contact
a professional financial adviser. Some material is copyrighted and published
under licence from ASX Operations Pty. Ltd. ACN 004523782.